Freenome said late Monday it closed its business combination with Perceptive Capital Solutions (PCSC), with the combined company expected to begin trading on Nasdaq under the "FRNM" ticker.
The combined company, to be renamed Freenome, is expected to have $310 million in gross proceeds, according to a statement.
Freenome will use the proceeds to advance its cancer detection tests, according to the company.